Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Electroconvulsive therapy

ECT patients view therapy positively

The majority of patients who undergo electroconvulsive therapy (ECT) think it was a positive experience and would undergo the treatment again, a study[1] has found.

In the research, which involved 30 NHS patients from Worcestershire, 80% said they thought ECT was a useful procedure and 70% said it worked quicker than drugs. Only 20% said they would be reluctant to have the treatment again.

“ECT is a very effective but underused treatment, partly due to the perception of the nature of this treatment,” says lead author Latha Guruvaiah. “This study illustrates that the overall experience and attitude of patients and carers on ECT treatment were positive.”

The study was based on questionnaires and interviews with patients, who underwent ECT during a two-year period at one NHS trust, and their carers. Most of the participants were female and the average age was 62 years.

Overall, 37% said ECT was a frightening treatment compared with 53% who disagreed. And 44% said they felt slightly or very anxious/frightened before ECT treatment. But overall, 80% said they would readily have the treatment again.

Reporting in Progress in Neurology and Psychiatry (online, 31 May 2017), the researchers note that ECT has been restricted to fewer and more serious conditions, such as severe depression and severe manic episodes. But they say the media’s portrayal of the treatment has probably contributed to negative perceptions and underuse.

They suggest that the introduction of ECT accreditation standards by the Royal College of Psychiatrists since 2003 has probably helped to improve the patient experience and made it less frightening for them and their carers.

“Many treatment options are available now for psychiatric disorders but still ECT is considered an effective treatment and has been found to be a potential lifesaver in many cases,” says Guruvaiah.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202940

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Application and Review of Pediatric Pharmacotherapy

    Application and Review of Pediatric Pharmacotherapy

    Increase your understanding of pharmacotherapy prescribed to pediatric patients with these realistic case studies.

    £33.00Buy now
  • Basic Pharmacokinetics

    Basic Pharmacokinetics

    A clear and concise basic pharmacokinetics textbook. Shows how to apply the principles to achieve successful drug therapy.

    £54.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Doctor's hand taking probe for electroconvulsive therapy

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.